Clinical Trial Update: Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atezolizumab with carboplatin and pemetrexed in chemotherapy-naïve patients with asymptomatic brain metastases from non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• CARBOPLATIN (Carboplatin)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Spanish Lung Cancer Group | Conditions: Non-small Cell Lung Cancer Stage IV | Phase 2 | Status: COMPLETED | Results posted: 2024-10-09